Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1998 4
2000 1
2001 2
2003 3
2004 7
2005 2
2007 1
2008 6
2009 2
2010 1
2011 2
2012 2
2013 7
2014 3
2015 2
2016 5
2017 6
2018 4
2019 4
2020 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
Büyükkaramikli NC, de Groot S, Fayter D, Wolff R, Armstrong N, Stirk L, Worthy G, Albuquerque de Almeida F, Kleijnen J, Al MJ. Büyükkaramikli NC, et al. Among authors: al mj. Pharmacoeconomics. 2018 Feb;36(2):145-159. doi: 10.1007/s40273-017-0581-6. Pharmacoeconomics. 2018. PMID: 29086363 Free PMC article. Review.
Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Büyükkaramikli NC, de Groot S, Riemsma R, Fayter D, Armstrong N, Portegijs P, Duffy S, Kleijnen J, Al MJ. Büyükkaramikli NC, et al. Among authors: al mj. Pharmacoeconomics. 2019 Feb;37(2):141-153. doi: 10.1007/s40273-018-0708-4. Pharmacoeconomics. 2019. PMID: 30194622 Free PMC article. Review.
Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Büyükkaramikli NC, Blommestein HM, Riemsma R, Armstrong N, Clay FJ, Ross J, Worthy G, Severens J, Kleijnen J, Al MJ. Büyükkaramikli NC, et al. Among authors: al mj. Pharmacoeconomics. 2017 Dec;35(12):1211-1221. doi: 10.1007/s40273-017-0528-y. Pharmacoeconomics. 2017. PMID: 28656543 Free PMC article. Review.
A microcosting study of intensive care unit stay in the Netherlands.
Tan SS, Hakkaart-van Roijen L, Al MJ, Bouwmans CA, Hoogendoorn ME, Spronk PE, Bakker J. Tan SS, et al. Among authors: al mj. J Intensive Care Med. 2008 Jul-Aug;23(4):250-7. doi: 10.1177/0885066608318661. Epub 2008 May 28. J Intensive Care Med. 2008. PMID: 18508839 Review.
Sample size calculation in economic evaluations.
Al MJ, van Hout BA, Michel BC, Rutten FF. Al MJ, et al. Health Econ. 1998 Jun;7(4):327-35. doi: 10.1002/(sici)1099-1050(199806)7:4<327::aid-hec342>3.0.co;2-u. Health Econ. 1998. PMID: 9683093
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer.
Holleman MS, Huygens SA, Al MJ, Kuppen MCP, Westgeest HM, van den Bergh ACM, Bergman AM, van den Eertwegh AJM, Hendriks MP, Lampe MI, Mehra N, van Moorselaar RJA, van Oort IM, Somford DM, de Wit R, van de Wouw AJ, Gerritsen WR, Groot CAU. Holleman MS, et al. Among authors: al mj. Drugs Real World Outcomes. 2022 Jun;9(2):275-285. doi: 10.1007/s40801-022-00294-7. Epub 2022 Mar 21. Drugs Real World Outcomes. 2022. PMID: 35314962 Free PMC article.
63 results